Antimicrobial Susceptibility Testing of Bacteria of Veterinary Origin

被引:1
作者
Watts, Jeffrey L. [1 ]
Sweeney, Michael T. [1 ]
Lubbers, Brian V. [2 ]
机构
[1] Zoetis Inc, Vet Med Res & Dev, Kalamazoo, MI 49009 USA
[2] Kansas State Vet Diagnost Lab, Manhattan, KS 66506 USA
关键词
IN-VIVO; PASTEURELLA-MULTOCIDA; INHIBITORY CONCENTRATION; MANNHEIMIA-HAEMOLYTICA; METHICILLIN-RESISTANT; ANTIBIOTIC-TREATMENT; CLINICAL-OUTCOMES; PHARMACODYNAMICS; INFECTIONS; VANCOMYCIN;
D O I
10.1128/microbiolspec.ARBA-0001-2017
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Antimicrobial susceptibility testing is an essential tool to the veterinarian for selecting the most appropriate agent for treatment of bacterial diseases of animals. The availability of well-defined methods that incorporate the necessary quality controls coupled to clinical outcome data is foundational in providing relevant test results for clinical decisions. Since 1993, the Clinical Laboratory and Standards Institute (CLSI) Subcommittee on Veterinary Antimicrobial Susceptibility Testing (VAST) has developed specific test methods and interpretive criteria for veterinary pathogens. This information has allowed for veterinarians to more effectively treat animal diseases thereby protecting both animal welfare and human food security. Moreover, the availability of standardized test methods for veterinary pathogens has allowed for the development of antimicrobial surveillance programs to detect the emergence of resistance among veterinary pathogens. Future work by the VAST and other groups will be critical to expanding the current test methods and interpretive criteria to more pathogen-antibacterial combinations, as well as, the incorporation of genomic information for routine antimicrobial susceptibility testing in the veterinary diagnostic laboratory.
引用
收藏
页数:16
相关论文
共 77 条
[21]   Use of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Caspofungin Susceptibility Testing of Candida and Aspergillus Species [J].
De Carolis, Elena ;
Vella, Antonietta ;
Florio, Ada R. ;
Posteraro, Patrizia ;
Perlin, David S. ;
Sanguinetti, Maurizio ;
Posteraro, Brunella .
JOURNAL OF CLINICAL MICROBIOLOGY, 2012, 50 (07) :2479-2483
[22]   Observations on macrolide resistance and susceptibility testing performance in field isolates collected from clinical bovine respiratory disease cases [J].
DeDonder, Keith D. ;
Harhay, Dayna M. ;
Apley, Michael D. ;
Lubbers, Brian V. ;
Clawson, Michael L. ;
Schuller, Gennie ;
Harhay, Gregory P. ;
White, Brad J. ;
Larson, Robert L. ;
Capik, Sarah F. ;
Riviere, Jim E. ;
Kalbfleisch, Ted ;
Tessman, Ronald K. .
VETERINARY MICROBIOLOGY, 2016, 192 :186-193
[23]  
DeRosa DC, 2000, J CLIN MICROBIOL, V38, P327
[24]  
Doern GV, 2011, J CLIN MICROBIOL, V49, P3109, DOI 10.1128/JCM.00580-11
[25]   PHARMACODYNAMICS OF A FLUOROQUINOLONE ANTIMICROBIAL AGENT IN A NEUTROPENIC RAT MODEL OF PSEUDOMONAS SEPSIS [J].
DRUSANO, GL ;
JOHNSON, DE ;
ROSEN, M ;
STANDIFORD, HC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (03) :483-490
[26]   Effects of inoculum size and incubation time on broth microdilution susceptibility testing of lactic acid bacteria [J].
Egervarn, Maria ;
Lindmark, Hans ;
Roos, Stefan ;
Huys, Geert ;
Lindgren, Sven .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2007, 51 (01) :394-396
[27]  
EUCAST, 2000, CLIN MICROBIOL INFEC, V6, P570
[28]  
European Committee for Antimicrobial Susceptibility Testing (EUCAST) of the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), 2000, Clin Microbiol Infect, V6, P570
[29]   Should we reevaluate antibiotic breakpoints? [J].
Ferraro, MJ .
CLINICAL INFECTIOUS DISEASES, 2001, 33 :S227-S229
[30]   PHARMACODYNAMICS OF INTRAVENOUS CIPROFLOXACIN IN SERIOUSLY ILL-PATIENTS [J].
FORREST, A ;
NIX, DE ;
BALLOW, CH ;
GOSS, TF ;
BIRMINGHAM, MC ;
SCHENTAG, JJ .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (05) :1073-1081